Insider Trading Activity ImmunoGen, Inc. (NASDAQ:IMGN) – Director Sold 46,667 shares of Stock

0

Insider Trading Activity For ImmunoGen, Inc. (NASDAQ:IMGN)

Daniel M Junius , Director of ImmunoGen, Inc. (NASDAQ:IMGN) reportedly Sold 46,667 shares of the company’s stock at an average price of 10.01 for a total transaction amount of $467,136.67 SEC Form

Insider Trading History For ImmunoGen, Inc. (NASDAQ:IMGN)

  • On 11/8/2012 Mark Alan Goldberg, Director, bought 3,000 with an average share price of $11.27 per share and the total transaction amounting to $33,810.00.
  • On 4/11/2013 James J O’leary, VP, sold 31,100 with an average share price of $17.37 per share and the total transaction amounting to $540,207.00.
  • On 5/1/2013 John Lambert, EVP, sold 11,250 with an average share price of $15.56 per share and the total transaction amounting to $175,050.00.
  • On 5/24/2013 James J O’leary, VP, sold 28,900 with an average share price of $18.11 per share and the total transaction amounting to $523,379.00.
  • On 6/3/2013 John Lambert, EVP, sold 11,250 with an average share price of $17.20 per share and the total transaction amounting to $193,500.00.
  • On 7/1/2013 John Lambert, EVP, sold 4,375 with an average share price of $16.80 per share and the total transaction amounting to $73,500.00.
  • On 7/3/2013 Daniel M Junius, CEO, sold 16,667 with an average share price of $17.31 per share and the total transaction amounting to $288,505.77.
  • Analyst Ratings History For ImmunoGen, Inc. (NASDAQ:IMGN)

    • On 8/5/2016 JPMorgan Chase & Co. Set Price Target of rating Hold with a price target of $9.00 to $5.00
    • On 3/1/2017 Morgan Stanley Lower Price Target of rating Underweight with a price target of $2.50 to $1.30
    • On 6/26/2017 William Blair Reiterated Rating Outperform
    • On 8/29/2017 Leerink Swann Reiterated Rating Outperform to Buy
    • On 8/29/2017 Cowen Reiterated Rating Hold
    • On 8/30/2017 Canaccord Genuity Reiterated Rating Buy with a price target of $8.00 to $10.00
    • On 10/12/2017 Jefferies Group Reiterated Rating Buy with a price target of $9.00

    Recent Trading Activity for ImmunoGen, Inc. (NASDAQ:IMGN)
    Shares of ImmunoGen, Inc. closed the previous trading session at 10.08 up +0.28 2.89% with shares trading hands.

    An ad to help with our costs